Homepage532983 • BOM
add
RPG Life Sciences Ltd
Vorige slotkoers
₹ 2.565,70
Dag-range
₹ 2.504,80 - ₹ 2.629,95
Jaar-range
₹ 1.540,00 - ₹ 2.976,70
Beurswaarde
41,73Â mld. INR
Gem. volume
2,00K
Koers/winst
22,74
Dividendrendement
0,79%
Primaire beurs
NSE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (INR) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,43Â mld. | 12,68% |
Bedrijfskosten | 742,50Â mln. | 14,97% |
Netto inkomsten | 1,17Â mld. | 786,33% |
Netto winstmarge | 82,01 | 686,29% |
Winst per aandeel | — | — |
EBITDA | 254,78Â mln. | 25,85% |
Effectief belastingtarief | 13,01% | — |
Balans
Totale activa
Totale passiva
| (INR) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 2,66Â mld. | 110,94% |
Totale activa | 6,58Â mld. | 28,26% |
Totale passiva | 1,27Â mld. | -7,78% |
Totaal aandelenvermogen | 5,31 mld. | — |
Uitstaande aandelen | 16,54 mln. | — |
Koers-boekwaardeverhouding | 8,00 | — |
Rendement op activa | — | — |
Rendement op kapitaal | 11,06% | — |
Kasstroom
Nettomutatie in liquide middelen
| (INR) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 1,17Â mld. | 786,33% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
Opgericht
1968
Website
Werknemers
1.331
